Close
Nordic 9Nordic 9

SkyGene (investor - Venture Capital)

Singapore skygene.bio
See something wrong or missing? Let us know
Offices:Singapore

Skygene is a venture capital firm in Singapore focused on supporting the next generation of bioprocessing and biotech companies.

Average round investment:3.55M USD
Average number per year:1.0
Distribution: 2026 (1)
Portfolio companies: Austria Valanx
Mostly invests in: Austria Austria (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to SkyGene

Name Criteria
Japan Fujifilm
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Austria
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland Urs Spitz
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Austria
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Axilium Capital
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Austria
  • Average number of deals per year: 1.1
  • Active last 12 months: Yes
Czech Republic Longevitytech.fund
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Austria
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Austria FFG - Austrian Research Promotion Agency
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Austria
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Austria LANA Ventures
72%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Austria
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Austria tecnet equity
71%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Austria
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
France Advent France Biotechnology
70%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Albert & Anna Göranssons Minne
70%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Belgium Annie Vereecken
70%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top